Abstract
This chapter illustrates recent changes in the global scenery and market for β-lactam antibiotics during the past 10 years and gives a comprehensive overview of current developments and future trends in their manufacture and their prospects in antibiotic therapy. Every aspect of their manufacture is covered in the first part, starting from genetics, biosynthesis and strategies for improving strains and their fermentation and ending with downstream processing, including their cleavage to 6-aminopenicillanic acid and 7-aminocephalosporanic acid and the according approaches for a general process economization. The second part outlines the therapeutic implications and mechanisms of β-lactam resistance, presents current strategies to overcome them, compiles the most recently commercialized β-lactam drug developments and finally gives an outlook on novel therapeutic approaches.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Aksoy DY, Unal S (2008) New antimicrobial agents for the treatment of Gram-positive bacterial infections. Clin Microbiol Infect 14:411–420
Amyes SGB, Miles RS (1998) Extended-spectrum beta lactamases: the role of inhibitors in therapy. J Antimicrob Chemother 42:415–417
Anderson SD, Gums JG (2008) Ceftobiprole: an extended-spectrum anti-methicillin-resistant Staphylococcus aureus cephalosporin. Ann Pharmacother 42:806–816
Ariyo BT, Bucke C, Keshavarz T (1997) Alginate oligosaccharides as enhancers of penicillin production in cultures of Penicillium chrysogenum. Biotechnol Bioeng 53:17–20
Arroyo M, de la Mata I, Hormigo D, Castillon MP, Acebal C (2005) Production and characterization of microbial β-lactam acylases. In: Mellado E, Barredo JL (eds) Microorganisms for industrial enzymes and biocontrol. Research Signpost, Trivandrum, pp 129–151
Barber MS, Giesecke U, Reichert A, Minas W (2004) Industrial enzymatic production of cephalosporin-based β-lactams. Adv Biochem Eng Biotechnol 88:179–215
Barredo JL, Diez B, Alvarez E, Martin JF (1989) Large amplification of 35-kb DNA fragment carrying two penicillin biosynthetic genes in high penicillin producing strains of P.chrysogenum. Curr Genet 16:453–459
Basch J, Franceschini T, Tonzi S, Chiang SJD (2004) Expression of a cephalosporin C esterase gene in Acremonium chrysogenum for the direct production of deacetylcephalosporin C. J Ind Microbiol Biotechnol 31:531–539
Bebbington C, Yarranton G (2008) Antibodies for the treatment of bacterial infections: current experience and future prospects. Curr Opin Biotechnol 19:613–619
Bianchi D, Bortolo R, Golini P, Cesti P (1998) Application of immobilized enzymes in the manufacture of beta-lactam antibiotics. Chim Ind 80:875–885
Binder RG, Numata K, Lowe DA, Murakami T, Brown JL (1993) Isolation and characterization of a Pseudomonas strain producing glutaryl-7-aminocephalosporanic acid acylase. Appl Environ Microbiol 59:3321–3326
Bovenberg AR, Koekman PB, Schipper D, Vollebregt WA (2002) Verfahren zur Herstellung von 7-ADCA durch Umsetzung Penicillins G mittels Expandase. German Patent DE6961–7228
Brakhage AA, Caruso ML (2004) Biotechnical genetics of antibiotic biosynthesis. In: Kueck U (ed.) Genetics and biotechnology. The Mycota II, 2nd edn. Springer, Berlin Heidelberg New York, pp 317–353
Brakhage AA, Sproete P, Al-Abdallah Q, Gehrke A, Plattner H, Tuencher, Andre (2004) Regulation of penicillin biosynthesis in filamentous fungi. Adv Biochem Eng Biotechnol 88:45–90
Bruno JG, Miner JC (2008) Therapeutic aptamers stabilized by 3′-conjugation to proteins. US Patent 2008 161 236
Bruno JG, Carillo MP, Phillips T (2008) In vitro antibacterial effects of antilipopolysaccharide DNA aptamer-C1qrs complexes. Fol Microbiol 53:295–302
Business Insights Report (2007) The global anti-infectives market outlook to 2011. Business Insights, London
Business Insights Report (2008) The global anti-infectives market outlook to 2013. Business Insights, London
Cairns BJ, Timms AR, Jansen VAA, Connerton IF, Payne RJH (2009) Quantitative models of in vitro bacteriophage-host dynamics and their application in phage therapy. PLoS Pathogens 5:e1000253
Campos C, Fernandez FJ, Sierra EC, Fierro F, Garay A, Barrios-Gonzalez J (2008) Improvement of penicillin yields in solid-state and submerged fermentation of Penicillium chrysogenum by amplification of the penicillin biosynthetic gene cluster. World J Microbiol Biotechnol 24:3017–3022
Cantwell CA, Beckmann RJ, Dotzlaf RJ, Fisher DL, Skatrud PL, Yeh WK, Queener SW (1990) Cloning and expression of a hybrid S.clavuligerus cefE gene in P.chrysogenum. Curr Genet 17:213–221
Cegelski L, Marshall GR, Eldridge GR, Hultgren SJ (2008) The biology and future prospects of antivirulence therapies. Nat Rev 6:17–27
Chandel AK, Rao LV, Narasu ML, Singh OV (2008) The realm of penicillin G acylase in β-lactam antibiotics. Enzyme Microb Technol 42:199–207
Christensen LH, Nielsen J, Villadsen J (1994) Degradation of penicillin V in fermentation media. Biotechnol Bioeng 44:165–169
Conder MJ, Crawford L, McAda PC, Rambosek JE (1992) Novel bioprocess for preparing 7-ADCA. European Patent EP 0532 341
Conder MJ, Almeida N, Behrens S, Crawford L, Delawder S, Hoerner T, McAda PC, Rambosek JE, Reeves C, Schimmell T, Stepan AM, Stieber R, Tong IT, Vinci V (1994) Cephalosporin production in Penicillium chrysogenum: the application of metabolic engineering to the development of a new biocatalytic process. Biotechnol Appl Biocatal 1994:20–24
Cornaglia G, Rossolini GM (2009) Forthcoming therapeutic perspectives for infections due to multidrug-resistant Gram-positive pathogens. Clin Microbiol Infect 15:218–223
Crawford L, Stepan AM, McAda PC, Rambosek JA, Conder MJ, Vinci VA, Reeves C (1995) Production of cephalosporin intermediates by feeding adipic acid to recombinant Penicillium chrysogenum strains expressing ring expansion activity. Bio/Technology 13:58–62
Davin-Regli A, Bolla JM, James CE, Lavigne JP, Chevalier J, Garnotel E, Molitor A, Pages JM (2008) Membrane permeability and regulation of drug «influx and efflux» in enterobacterial pathogens. Curr Drug Targets 9:750–759
De la Mata IAM, Castillon MP, Acebal C (2005) Production and characterization of enzymes involved in the industrial production of semisynthetic β-lactam antibiotics. Rec Res DevAppl Microbiol Biotechnol 2:1–20
Delcour AH (2009) Outer membrane permeability and antibiotic resistance. Biochim Biophys Acta 1794:808–816
Del Pozo JL, Patel R (2008) Ceftobiprole medocaril: a new generation β-lactam. Drugs Today 44:801–825
Demain AL, Zhang J (1998) Cephalosporin C production by Cephalosporium acremonium: the methionine story. Crit Rev Biotechnol 18:283–294
Deresinski SC (2008) Ceftobiprole: breaking therapeutic dogmas of the β-lactam class. Diagn Microbiol Infect Dis 61:82–85
DiGuilmi AM, Mouz N, Martin L, Hoskins J, Jaskunas SR, Dideberg O, Vernet T (1999) Glycosyltransferase domain of penicillin-binding protein 2a from Streptococcus pneumoniae is membrane assiciated. J Bacteriol 181:2773–2781
Dreyer J, Eichhorn H, Friedlin E, Kürnsteiner H, Kück U (2009) A homologue of the Aspergillus velvet gene regulates both cephalosporin C biosynthesis and hyphal fragmentation in Acremonium chrysogenum. Appl Env Microbiol 73:3412–3422
Elmayergi H, Moo-Young M (1973) Effect of a polymer additive on mass transfer into mold pellets. In: Sikyta B (ed) Advances in microbial engineering. Biotechnol Bioeng Symp 4:507–512
Evers ME, Trip H, van den Berg MA, Bovenberg RAL, Driessen AJM (2004) Compartmentalization and transport in beta-lactam antibiotics biosynthesis. Adv Biochem Eng Biotechnol 88:111–135
Feng B, Friedlin E, Marzlug GA (1994) A reporter gene analysis of penicillin biosynthesis gene expression in Penicillium chrysogenum and its regulation by nitrogen and glucose catabolite repression. Appl Env Microbiol 60:4432–4439
Fierro F, Barredo JL, Diez B, Guiterrez S, Fernandez J, Martin JF (1995) The penicillin cluster is amplified in tandem repeats linked by conserved hexanucleotide sequences. Proc Natl Acad Sci USA 92:6200–6204
French GL (2008) What’s new and not so new on the antimicrobial horizon? Clin Microbiol Infect 14:19–29
Fritz-Wolf K, Koller KP, Lange G, Liesum A, Sauber K, Schreuder K, Kabsch W (2002) Structure based prediction of modifications in glutarylamidase to allow single-step enzymatic production of 7-aminocephalosporanic acid from cephalosporin C. Prot Sci 11:92–103
Fukagawa M, Isogai T, Aramori I, Iwami M, Kojo H, Ono T, Kohsaka M, Imanaka H (1991) Direct production of 7-aminodeacetylcephalosporanic acid by Acremonium chrysogenum Hm 178. Agric Biol Chem 55:2163–2165
Gales AC, Sader HS (2008) Novel β-lactams. Braz J Infect Dis 12:46–58
Goo KS, Chun S, Sim TS (2008) Relevant double mutations in bioengineered Streptomyces clavuligerus deacetoxycephalosporin C synthase result in higher binding specificities which improve penicillin bioconversion. Appl Env Microbiol 74:1167–1175
Gosh AC, Bora MM, Dutta NN (1996) Developments in liquid membrane separation of beta-lactam antibiotics. Bioseparation 6:91–105
Gosh AC, Mathur RK, Dutta NN (1997) Extraction and purification of cephalosporin antibiotics. Adv Biochem Eng Biotechnol 56: 111–145
Gupta V (2007) An update on newer β-lactamases. Ind J Med Res 126:417–427
Heim J, Shen Y, Wolfe S, Demain AL (1984) Regulation of isopenicillin N synthetase and deacetoxycephalosporin C synthetase by carbon source during the fermentation of Cephalosporin acremonium. Appl Microbiol Biotechnol 19:232–236
Ho CS, Lu-Kwang J, Baddour RF (1990) Enhancing penicillin fermentations by increased oxygen solubility through the addition of n-hexadecane. Biotechnol Bioeng 36:1110–1118
Hönlinger C, Kubicek CP (1989) Regulation of δ-(L-α-aminoadipyl)-L-cysteinyl-D-valine and isopenicillin N biosynthesis in Penicillium chrysogenum by the α-aminoadipate pool size. FEMS Microbiol Lett 65:71–76
Hou X, Hu Z, Chen G, Li Y, Wang B, Li W (2009) Antibacterial mechanism and their therapeutic use of antimicrobial peptides. Weishengwuxue Tongbao 36:97–105
Inal JM (2003) Phage therapy: a reappraisal of bacteriophages as antibiotics. Arch Immun Ther Exp 51:237–244
Ingolla TD, Queener SW, Samson SM, Skatrud PL (1988) Recombinant DNA expression vectors and DNA compounds that encode deacetoxycephalosporin C synthetase and deacetylcephalosporin C synthetase. European Patent 0281 391
Isogai T (1997) New processes for production of 7-aminocephalosporanic acid from cephalosporin. Drugs Pharm Sci 82:733–751
Isogai T, Fukagawa M (1991) Direct production of 7-aminocephalosporanic acid and 7-aminodeacetylcephalosporanic acid by recombinant Acremonium chrysogenum. Actinomycetology 5:102–111
Isogai T, Fukagawa M, Aramori I, Iwami M, Kojo H, Ono T, Ueda Y, Kohsaka M, Imanaka H (1991) Construction of 7-aminocephalosporanic acid (7-ACA) biosynthesis operon and direct productionof 7-ACA in Acremonium chrysogenum. Bio/Technology 9:188–191
Jacoby GA (2006) β-Lactamase nomenclature. Antimicrob Agent Chemother 50:1123–1129
Jagusztyn-Krynicka EK, Wyszynska A (2008) The decline of the antibiotic era - new approaches for antibacterial drug discovery. Pol J Microbiol 57:91–98
Karaffa L, Sandor E, Kozma J, Szentirmai A (1996) Cephalosporin C production, morphology and alternative respiration of Acremonium chrysogenum in glucose limited chemostat. Bioechnol Lett 18:701–706
Karaffa L, Sandor E, Kozma J, Kubicek CP, Szentirmai A (1999) The role of the alternative respiratory pathway in the stimulation of cephalosporin C formation by soybean oil in Acremonium chrysogenum. Appl Microbiol Biotechnol 51:633–638
Keam SJ (2008) Doripenem: a review of its use in the treatment of bacterial infections. Drugs 68:2021–2057
Koller KP, Lange G, Sauber K, Fritz-Wolf K, Kabsch W (2002) Structure based modelling and engineering of glutarylamidase for single-step enzymatic production of 7-aminocephalosporanic acid from cephalosporin C. Patent WO 2002072806
Küenzi MT (1980) Regulation of cephalosporin synthesis in Cephalosporium acremonium by phosphate and glucose. Arch Microbiol 128:78–83
Li B, Li S, Zhou Y, Zhao X, Zhu B (2006) Cloning and expression of Vitreoscilla haemoglobin gene (vgb) in Penicillium chrysogenum. Zhongguo Kangshengsu Zazhi 31:400–402
Liras P, Asturias JA, Martin JF (1990) Phosphate control sequences involved in transcriptional regulation of antibiotic biosynthesis. Trends Biotechnol 8:184–188
Lodise TP, Patel N, Renaud-Mutart A, Gorodecky E, Fritsche TR, Jones RN (2008) Pharmacokinetic and pharamcodynamic profile of ceftobiprole. Diagn Microbiol Infect Dis 61:96–102
Lopez-Gallego F, Batencor L, Hidalgo A, Mateo C, Fernandez-Lafuente R, Guisan JM (2005) One-pot conversion of cephalosporin C to 7-aminocephalosporanic acid in the absence of hydrogen peroxide. Adv Synth Catal 347:1804–1810
Lornovskaja O, Zgurskaya HI, Bostian KA, Lewis K (2008) Multidrug efflux pumps. structure, mechanism and inhibition. In: Wax RG (ed) Bacterial resistance to antimicrobials, 2nd edn, CRC, Boca Raton, pp 45–69
Lu TK, Collins JJ (2009) Engineered bacteriophage targeting gene networks as adjuvants for antibiotic therapy. Proc Natl Acad Sci USA 106:4629–4634
Lübbe C, Jensen SE, Demain AL (1984) Prevention of phosphate inhibition of cephalosporin synthetases by ferrous ion. FEMS Microbiol Lett 25:75–90
Luo H, Li Q, Yu H, Shen Z (2004) Construction and application of fusion proteins of D-amino acid oxidase and glutaryl-7-aminocephalosporanic acid acylase for direct bioconversion of cephalosporin C to 7-aminocephalosporanic acid. Biotechnol Lett 26:939–945
Martin JF (1998) New aspects of genes and enzymes for β-lactam antibiotic synthesis. Appl Microbiol Biotechnol 50:1–15
Martin JF, Casqueiro J, Kosalkova K, Marcos AT, Gutierrez S (1999) Penicillin and cephalosporin biosynthesis: mechanism of carbon catabolite regulation of penicillin production. Antonie van Leeuwenhoek 75:21–31
Matsumara M, Yoshida T, Taguchi H (1982) Synthesis of cephalosporin C by a methionine analogue resistant mutant of Cephalosporium acremonium. Eur J Appl Microbiol Biotechnol 16:114–118
Meinke A, Nagy E, Hanner, M, Dewasthaly S, Stierschneider U (2004) Streptococcus pneumoniae antigens, polynucleotides, and antibodies for antagonist screening and for diagnosis and therapy of bacterial infection. Patent WO 2004 092 209
Morrissey D, Haeberli P (2005) Nucleic acid mediated inhibitor of cytolysin toxin activity and uses thereof for diagnosis and for inhibiting enterococcus infection. US Patent 20050209182
Mugnier P, Podglajen I, Goldstein FW, Collatz E (1998) Carbapenems as inhibitors of OXA-13, a novel, integron-encoded β-lactamase in Pseudomonas aerigunosa. Microbiology 144:1021–1031
Nagy E, Giefing C, von Gabain A (2008) Anti-infective antibodies: a new tool to prevent and to treat nosocomial diseases. Exp Rev Anti-Infect Ther 6:21–30
Ni N, Li M, Wang J, Wang B (2009) Inhibitors and antagonists of bacterial quorum sensing. Med Res Rev 29:65–124
Nishino K (2008) Roles of drug efflux pumps in bacterial drug resistance and virulence. Analysis to identify novel drug targets and counteract multidrug resistance and virulence. Jpn J Antibiot 61:105–113
Nukaga M, Bethel CR, Thomson JM, Hujer AM, Distler A, Anderson VE, Knox JR, Bonomo RA (2008) Inhibition of class A β-lactamases by carbapenems: crystallographic observation of two conformations of meropenem in SHV-1. J Am Chem Soc 130:12656–12662
Oh B, Kim K, Park J, Yoon J, Han D, Kim Y (2004) Modifying the substrate specificity of penicillin G acylase by mutating active-site residues. Biochem Biophys Res Commun 319:486–492
O’Neill A (2008) New antibacterial agents treating infections caused by multi-drug resistant Gram-negative bacteria. Exp Opin Inv Drugs 17:297–302
Otten LG, Sio CF, Vrielink JC, Robbert H, Quax WJ (2002) Altering the substrate specificity of cephalosporin acykase by directed evolution of the subunit. J Biol Chem 277:42121–42127
Otten LG, Sio CF, Reis CR, Koch G, Cool RH, Quax WJ (2007) A highly active adipyl-cephalosporin acylase obtained via rational randomization. FEBS J 274:5600–5610
Pages JM, James CE, Winterhalter M (2008) The porin and the permeating antibiotic: a selective diffusion barrier in gram-negative bacteria. Nat Rev Microbiol 8:893–903
Perez F, Salata RA, Bonomo RA (2008) Current and novel antibiotics against resistant Gram-positive bacteria. Infect Drug Res 1:27–44
Pollegioni L, Lorenzi S, Rosini L, Marcone GL, Molla G, Verga R, Cabri W, Pilone MS (2005) Evolution of an acylase active on cephalosporin C. Protein Sci 14:3064–3076
Poole K (2007) Efflux pumps as antimicrobial resistance mechanisms. Ann Med 39:162–176
Prezelj A, Urleb U, Solmajer T (2008) Antibacterial combination of a tricyclic carbapenem and an antibiotic. Patent WO 2008098955
Pusztahelyi T, Pocsi I, Kozma J, Szentirmai A (1997) Aging of Penicillium chrysogenum cultures under carbon starvation: I: morphological changes and secondary metabolism. Biotechnol Appl Biochem 81–86
Revilla G, Lopez-Nieto MJ, Luengo JM, Martin JF (1984) Carbon catabolite repression of penicillin biosynthesis by Penicillium chrysogenum. J Antibiot 37:781–789
Revilla G, Ramos FR, Lopez-Nieto MJ, Alvarez E, Martin JF (1986) Glucose represses formation of δ-(L-α-aminoadipyl)-L-cysteinyl-D-valine and isopenicillin N synthase but not penicillin acyltransferase in Penicillium chrysogenum. J Bacteriol 168: 947–952
Rodrigues de Oliveira J, Nunes FB, Pires MGS, Melo DA, Donadio MVF (2008) Antibodies as anti-infective agents in medicinal chemistry. Anti-Infect Agents Med Chem 7:249–257
Rodriguez-Saiz M, de la Fuente JL, Barredo JL (2005) Metabolic engineering of Acremonium chrysogenum to produce deacetoxycephalosporin C and bioconversion to 7-aminodeacetoxycephalosporanic acid. Methods Biotechnol 18:41–64
Savjani JK, Gajjar AK, Savjani KT (2009) Mechanisms of resistance: useful tool to design antibacterial agents for drug resistant bacteria. Mini-Rev Med Chem 9:194–205
Schafer JJ, Goff DA, Mangino JE (2009) Doripenem: a new addition to the carbapenem class of antimicrobials. Rec Patents Anti-Infect Drug Discov 4:18–28
Schmidt FR (2004) The challenge of multidrug resistance. Appl Microbiol Biotechnol 63:355–343
Schmidt FR (2005a) About the nature of RNA interference. Appl Microbiol Biotechnol 67:429–435
Schmidt FR (2005b) Optimization and scale-up of industrial fermentation processes. Appl Microbiol Biotechnol 68:425–435
Schmitt EK, Hoff B, Kueck U (2004) Regulation of cephalosporin biosynthesis. Adv Biochem Eng Biotechnol 88:1–43
Shen YQ, Heim J, Solomon NA, Wolfe S, Demain AL (1984) Repression of β-lactam production in Cephalosporium acremonium by nitrogen sources. J Antibiot 37:503–511
Sio CF, Quax WJ. (2004) Improved β-lactam acylases and their use as industrial biocatalysts. Curr Opin Biotechnol 15:349–355
Sio CF, Riemens AM, van der Laan JM, Verhaert RMD, Quax WJ (2002) Directed evolution of a glutary acylase into adipyl acylase. Eur J biochem 269:4495–4504
Sio CF, Otten LG, Cool RH, Quax WJ (2003) Analysis of a substrate specificity switch residue of cephalosporin acylase. Biochem Biophys Res Commun 312:755–760
Sio CF, Otten LG, Cool RH, Quax WJ (2005) Design of glutarylamidase mutant variants from Pseudomonas SY-77 for the preparation of 7-aminocephalosporanic acid from cephalosporin C. Patent WO 2005054452
Skalweit Helfand M (2008) β-Lactams against emerging superbugs: progress and pitfalls. Expert Rev Clin Pharmacol 1:559–571
Skatrud PL (1992) Genetic engineering of β-lactam antibiotic biosynthetic pathways in filamentous fungi. Trends Biotechnol 10:324–329
Skatrud PL, Schwecke T, van Liempt H, Tobin MB (1997) Advances in the molecular genetics of β-lactam antibiotic biosynthesis. In: Kleinkauf H, von Doehren H (eds) Biotechnology, 2nd edn. American Chemical Society, Columbus, pp 247–276
Svarovsky S, Joshi L (2008) Biocombinatorial selection of carbohydrate binding agents of therapeutic significance. Curr Drug Discov Technol 5:20–28
Teijeira F, Ullan RV, Guerra SM, Garcia-Estrada C, Vaca I, Martin JF (2009) The transporter cefM involved in translocation of biosynthetic intermediates is essential for cephalosporin production. Biochem J 418:113–124
Usher J, Lewis MA, Hughes DW, Compton BJ (1988) Development of the cephalosporin C fermentation taking into account the instability of cephalosporin C. Biotechnol Lett 10:343–348
van den Berg MA, Albang R, Albermann K, Badger JH, Daran JM, Driessen AJM, Garcia-Estrada C, Fedorova ND, Harris DM, Heijne WHM, Joardar V, Kiel JAKW, Kovalchuk A, Martin JF, Nierman WC, Nijland JG, Pronk JT, Roubos JA, van der Klei IJ, van Peij NME, Veenhuis M, von Doehren H, Wagner C, Wortman J, Bovenberg RAL (2008) Genome sequencing and analysis of the filamentous fungus Penicillium chrysogenum. Nat Biotechnol 26:1161–1168
van Suijdam JC, Kossen NWF, Paul PG (1980) An inoculum technique for the production of fungal pellets. Eur J Appl Microbiol Biotechnol 10:211–221
Velasco J, Adrio JL, Moreno MA, Diez B; Esteban Morales M, Bernasconi E, Barredo JL (2000a) Production of 7-aminodesacetoxycephalosporanic acid by culture of cefE-expressing Acremonium mutants and enzymic conversion of desacetoxycephalosporin C. Patent DO2000078989
Velasco J, Adrio JL, Moreno MA, Diez B, Soler G, Barredo JL (2000b) Acremonium chrysogenum. Nat Biotechnol 18:857–861
Vergidis PI, Falagas ME (2008) New antibiotic agents for bloodstream infections. Int J Antimicrob Ag 32:S60-S65
Wang W, Zheng X (2008) Progress on research and application of antibacterial peptide. Guoji Yixue Jishengchongbing Zazhi 35:52–56
Wang Y, Mealy N (2008) Ceftaroline fosamil: cephalosporin antibiotic. Drugs Fut 33:302–308
Wei CL, Yang YB, Wang WC, Liu WC, Hsu JS, Tsai YC (2003) Engineering Streptomyces clavuligerus deacetoxycephalosporin C synthase for optimal ring expansion activity toward penicillin G. Appl Env Microbiol 69:2306–2312
Weil J, Miramonti J, Ladisch MR (1995) Biosynthesis of cephalosporin C: regulation and recombinant technology. Enzyme Microb Technol 17:88–90
Wilmouth RC, Westwood NJ, Anderson K, Brownlee W, Claridge TD, Clifton IJ (1998) Inhibition of elastase by N-sulfonylaryl beta-lactams: anatomy of a stable acyl-enzyme complex. Biochemistry 37:17506–17513
Xu P, Ren Z, Wang F, Feng M, Zhang J, Dai M, Wei C, Mu M, Jia Q (2006) Increase penicillin production by Penicillium chrysogenum expressing Vitreoscilla Hb (VHb). Patent CN 2004–10092430
Yong Kim E, Young JY (1992) Analysis of broth rheology with cell morphology in Cephalosporium fermentation. Biotechnol Tech 6:501–506
Zhang J, Demain A (1992) ACV synthetase. Crit Rev Biotechnol 12:245–260
Zhang J, Greasham R (1999) Chemically defined media for commercial fermentations. Appl Microbiol Biotechnol 51:407–421
Zhang J, Wolfe S, Demain AL (1988) Phosphate repressible and inhibitible β-lactam synthetases in Cephalosporium acremonium strain C-10. Appl Microbiol Biotechnol 29:242–247
Zhang J, Wolfe S, Demain AL (1989) Carbon source regulation of the ACV synthetase in Cephalosporium acremonium C-10. Curr Microbiol 18:361–367
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2011 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Schmidt, FR. (2011). The β-Lactam Antibiotics: Current Situation and Future Prospects in Manufacture and Therapy. In: Hofrichter, M. (eds) Industrial Applications. The Mycota, vol 10. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-11458-8_5
Download citation
DOI: https://doi.org/10.1007/978-3-642-11458-8_5
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-11457-1
Online ISBN: 978-3-642-11458-8
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)